$DT

Tech M&A deals: Dynatrace, Arize AI, Space

Dynatrace agreed to acquire Arize AI for $915 million, including about $815 million cash plus replacement equity. Dynatrace expects the deal to add ~200 bps to annual recurring revenue growth in FY2027 and cut non-GAAP operating margin by ~175 bps, funded via cash and/or its credit facility, subject to approvals. Space-Eyes plans a McKinley SPAC merger valuing it at ~$638 million pro forma. adesso acquired omni:us; terms undisclosed.

Original reporting
Published Aug 14, 2026, 5:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 5:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tech M&A deals: Dynatrace, Arize AI, Space — source image
Decision brief

The 30-second read

$DTNeutralMed
01

Why it matters

Dynatrace-Arize provides explicit growth and margin guidance tied to deal close timing, while Space-Eyes-CUAS provides SPAC mechanics and a targeted Nasdaq trading ticker. adesso omni:us adds an insurance AI capability but without disclosed financial terms.

02

Market read

Traders can model deal-driven valuation and financing/leverage sensitivity for Dynatrace, and pre-close speculative risk for the Space-Eyes SPAC structure.

03

What to watch

Regulatory approval timing and the cash vs credit-facility financing mix for Dynatrace, plus earn-out share mechanics and PIPE execution risk for the Space-Eyes SPAC, could dominate near-term trading outcomes.

Relevance 8/10Novelty 8/10Timing: deal announcements with closing targeted later in 2026 and early FY2027 impact guidance

Background

The article is a multi-deal M&A roundup focused on AI and vertical software transactions.

Company-level read

Ticker impact

$DTNeutralMedium confidence
Context

Dynatrace agreed to acquire Arize AI for $915M, adding 200 bps ARR growth in FY2027 but cutting non-GAAP operating margin by 175 bps.

Expected impact

Near-term volatility likely around deal terms and margin dilution; longer-term depends on ARR realization.

Evidence & confidence

The article provides both growth accretion and margin headwind plus timing tied to regulatory approvals and quarter/quarterly close.

Market effects

AI observability and insurance-claims automation deals reinforce consolidation and product bundling in enterprise AI infrastructure.

adesso is German, but the transaction is framed as strengthening its insurance AI platform rather than a region-specific macro catalyst.

Cross-border tech M&A signals continued capital availability for AI tooling and vertical AI applications.

Counterpoint

Margin dilution (175 bps) could outweigh ARR accretion if Arize monetization lags, making the deal less value-accretive than headline growth implies.

Key entities

  • Dynatrace

    Agreed to acquire Arize AI for $915M, with FY2027 ARR growth and non-GAAP margin impact guidance.

  • Arize AI

    AI observability specialist providing model evaluation, observability, and telemetry capabilities.

  • Space-Eyes

    Agreed to go public via business combination with McKinley Acquisition Corp, targeting Nasdaq trading under CUAS.

  • McKinley Acquisition Corp

    SPAC counterpart providing trust and PIPE proceeds for the Space-Eyes transaction.

  • adesso

    Acquired 100% of omni:us to strengthen its insurance AI platform.

Related articles

$DTMedAI 8/10

Dynatrace Pays $915 Million To Move AI Evaluation Upstream

Dynatrace agreed Aug. 13 to acquire Arize in a cash-and-stock deal valued at $915 million to expand into the AI developer community. Dynatrace said it will fund the purchase with cash on hand or its credit facility, with closing expected this quarter or early next. The company guided to about 200 bps ARR accretion and 175 bps non-GAAP operating margin dilution.

$DTMed

Markets round-up: Dynatrace, IGEL, MongoDB

Dynatrace will acquire Arize for $915m in cash and stock, including about $815m in cash and replacement equity awards, to expand AI observability. IGEL partnered with Menlo Security for zero-trust browser access. MongoDB made Atlas available via an MCP server for tools like Claude Code. Okta said an AI agent feature can cut token costs up to 89%.

$DTHighAI 9/10

Dynatrace (DT) Q1 2027 Earnings Call Transcript

Dynatrace (DT) reported Q1 fiscal 2027 results on an earnings call. Total ARR was $2.14B, up 17% constant currency. Net new ARR was $85M, with $13M from Bindplane. Total revenue was $554.5M, up 15% constant currency. Non-GAAP EPS was $0.48. Fiscal 2027 guidance: ARR $2.359B to $2.379B and revenue $2.306B to $2.320B.

$DTMed

5 Insightful Analyst Questions From Dynatrace’s Q2 Earnings Call

Dynatrace (DT) reported Q2 revenue of $554.5M, slightly above estimates of $549.7M, with adjusted EPS of $0.48 vs $0.44. Management said enterprise adoption and platform consolidation drove results, and AI contributed to platform consumption, AI observability demand, and agent monetization. Full-year revenue guidance was cut to $2.31B midpoint, while adjusted EPS guidance rose to $1.98.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DTHighAI 9/10

Dynatrace Q1 Earnings Call Highlights

Dynatrace (NYSE:DT) reported $309 million in adjusted free cash flow in Q1 and said it changed its FCF definition to exclude certain non-recurring cash expenses. It added 122 new customer logos, with average land size near $285,000 and net retention around 110% (trailing 12 months). Log management grew over 100% to nearly $200 million annualized consumption. Management maintained FY ARR growth outlook (15.5% to 16.5%), raised FY27 revenue growth, and guided non-GAAP EPS to $1.97 to $1.99.